Skip to main content
HR 1068 108th Congress House Health Accreditation (Medical care) Administrative procedure Blood diseases Cardiovascular diseases Caregivers Child health Clinical trials Communication in medicine Communication in science Congress Congressional reporting requirements Cost effectiveness Department of Health and Human Services Diabetes Donation of organs, tissues, etc. Economics and Public Finance Executive reorganization Eye diseases Families

Pancreatic Islet Cell Transplantation Act of 2003

Introduced: March 4, 2003 See on congress.gov
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Mar 14, 2003
Referred to the Subcommittee on Health.
Mar 4, 2003
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Mar 4, 2003
Sponsor introductory remarks on measure. (CR E352-353)
Mar 4, 2003
Introduced in House
 Plain-English summary Congressional Research Service
Pancreatic Islet Cell Transplantation Act of 2003 - Amends the Public Health Service Act to include pancreases procured by an organ procurement organization and used for islet cell transplantation or research to be counted toward organ procurement organization certification.

Establishes the Interagency Committee on Islet Cell Transplantation within the Department of Health and Human Services (HHS). Requires the Committee to study related issues, including Federal research funding, the effect of specified policies on transplantation, and data collection.

Instructs the Secretary of HHS to request the Institute of Medicine to provide a study of the impact of islet cell transplantation on juvenile diabetes patients, including their health and the treatment's cost-effectiveness.

Directs the Secretary, acting through the Administrator of the Centers for Medicare & Medicaid Services, to establish a demonstration project to assess the efficacy of pancreatic cell islet transplantation for individuals who: (1) have Type I (juvenile) diabetes; and (2) have end-stage renal disease; and (3) are Medicare beneficiaries. Establishes reporting requirements.

What's happening now March 14, 2003

Referred to the Subcommittee on Health.

 Committees of jurisdiction 3